# Alliance Resource Partners LP: financial statements, quarterly

ARLP · Nasdaq · CIK 1086600 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/arlp.md) · [Financials](/companies/arlp/financials.md) · [Filings](/companies/arlp/filings.md) · [Insiders](/companies/arlp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/arlp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [637](/filings/0001558370-24-014867.md) | [625 d](/filings/0001104659-26-020468.md) | [652](/filings/0001558370-25-007175.md) | [593](/filings/0001558370-25-010804.md) | [614](/filings/0001104659-25-108518.md) | [590 d](/filings/0001104659-26-020468.md) | [540](/filings/0001104659-26-057964.md) | [547](/filings/0001104659-26-092001.md) | [571](/filings/0001104659-25-108518.md) | [536 d](/filings/0001104659-26-020468.md) | [516](/filings/0001104659-26-057964.md) | [552](/filings/0001104659-26-092001.md) |
| Operating income | $m | [165](/filings/0001558370-24-014867.md) | [116 d](/filings/0001104659-26-020468.md) | [160](/filings/0001558370-25-007175.md) | [117](/filings/0001558370-25-010804.md) | [101](/filings/0001104659-25-108518.md) | [15.3 d](/filings/0001104659-26-020468.md) | [94.3](/filings/0001104659-26-057964.md) | [88.7](/filings/0001104659-26-092001.md) | [105](/filings/0001104659-25-108518.md) | [97.3 d](/filings/0001104659-26-020468.md) | [21.9](/filings/0001104659-26-057964.md) | [95.6](/filings/0001104659-26-092001.md) |
| Interest expense | $m | [7.7](/filings/0001558370-23-018162.md) | [6.2 d](/filings/0001558370-24-001616.md) | [7.7](/filings/0001558370-24-007517.md) | [9.3](/filings/0001558370-25-010804.md) | [9.5](/filings/0001104659-25-108518.md) | [8.7 d](/filings/0001104659-26-020468.md) | [8.4](/filings/0001104659-26-057964.md) | [9.3](/filings/0001104659-26-092001.md) | [11.0](/filings/0001104659-25-108518.md) | [11.0 d](/filings/0001104659-26-020468.md) | [11.7](/filings/0001104659-26-057964.md) | [12.6](/filings/0001104659-26-092001.md) |
| Income tax | $m | [3.4](/filings/0001558370-24-014867.md) | [(3.4) d](/filings/0001104659-26-020468.md) | [4.9](/filings/0001558370-25-007175.md) | [3.9](/filings/0001558370-25-010804.md) | [4.1](/filings/0001104659-25-108518.md) | [3.0 d](/filings/0001104659-26-020468.md) | [4.2](/filings/0001104659-26-057964.md) | [5.3](/filings/0001104659-26-092001.md) | [5.9](/filings/0001104659-25-108518.md) | [3.3 d](/filings/0001104659-26-020468.md) | [2.7](/filings/0001104659-26-057964.md) | [6.2](/filings/0001104659-26-092001.md) |
| Net income | $m | [154](/filings/0001558370-24-014867.md) | [115 d](/filings/0001104659-26-020468.md) | [158](/filings/0001558370-25-007175.md) | [100](/filings/0001558370-25-010804.md) | [86.3](/filings/0001104659-25-108518.md) | [16.3 d](/filings/0001104659-26-020468.md) | [74.0](/filings/0001104659-26-057964.md) | [59.4](/filings/0001104659-26-092001.md) | [95.1](/filings/0001104659-25-108518.md) | [82.7 d](/filings/0001104659-26-020468.md) | [9.1](/filings/0001104659-26-057964.md) | [79.6](/filings/0001104659-26-092001.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [197](/filings/0001558370-23-018162.md) | [59.8](/filings/0001558370-25-001805.md) | [134](/filings/0001558370-24-007517.md) | [204](/filings/0001558370-24-011365.md) | [195](/filings/0001558370-24-014867.md) | [137](/filings/0001104659-26-020468.md) | [81.3](/filings/0001558370-25-007175.md) | [55.0](/filings/0001558370-25-010804.md) | [94.5](/filings/0001104659-25-108518.md) | [71.2](/filings/0001104659-26-092001.md) | [28.9](/filings/0001104659-26-057964.md) | [111](/filings/0001104659-26-092001.md) |
| Current assets | $m | [588](/filings/0001558370-23-018162.md) | [516](/filings/0001558370-25-001805.md) | [631](/filings/0001558370-24-007517.md) | [685](/filings/0001558370-24-011365.md) | [627](/filings/0001558370-24-014867.md) | [513](/filings/0001104659-26-020468.md) | [477](/filings/0001558370-25-007175.md) | [461](/filings/0001558370-25-010804.md) | [486](/filings/0001104659-25-108518.md) | [430](/filings/0001104659-26-092001.md) | [409](/filings/0001104659-26-057964.md) | [509](/filings/0001104659-26-092001.md) |
| Total assets | $m | [2,814](/filings/0001558370-24-014867.md) | [2,788](/filings/0001104659-26-020468.md) | [2,966](/filings/0001558370-25-007175.md) | [3,053](/filings/0001558370-25-010804.md) | [3,032](/filings/0001104659-25-108518.md) | [2,916](/filings/0001104659-26-020468.md) | [2,903](/filings/0001104659-26-057964.md) | [2,869](/filings/0001104659-26-092001.md) | [2,908](/filings/0001104659-25-108518.md) | [2,854](/filings/0001104659-26-092001.md) | [2,856](/filings/0001104659-26-057964.md) | [2,942](/filings/0001104659-26-092001.md) |
| Current liabilities | $m | [274](/filings/0001558370-23-018162.md) | [227](/filings/0001558370-25-001805.md) | [304](/filings/0001558370-24-007517.md) | [271](/filings/0001558370-24-011365.md) | [265](/filings/0001558370-24-014867.md) | [233](/filings/0001104659-26-020468.md) | [247](/filings/0001558370-25-007175.md) | [235](/filings/0001558370-25-010804.md) | [256](/filings/0001104659-25-108518.md) | [204](/filings/0001104659-26-092001.md) | [280](/filings/0001104659-26-057964.md) | [290](/filings/0001104659-26-092001.md) |
| Total liabilities | $m | [961](/filings/0001558370-23-018162.md) | [930](/filings/0001558370-25-001805.md) | [1,044](/filings/0001558370-24-007517.md) | [1,119](/filings/0001558370-24-011365.md) | [1,107](/filings/0001558370-24-014867.md) | [1,062](/filings/0001104659-26-020468.md) | [1,071](/filings/0001558370-25-007175.md) | [1,057](/filings/0001558370-25-010804.md) | [1,077](/filings/0001104659-25-108518.md) | [994](/filings/0001104659-26-092001.md) | [1,073](/filings/0001104659-26-057964.md) | [1,155](/filings/0001104659-26-092001.md) |
| Long-term debt | $m | [321](/filings/0001558370-23-018162.md) | [317](/filings/0001558370-25-001805.md) | [355](/filings/0001558370-24-007517.md) | [462](/filings/0001558370-24-011365.md) | [456](/filings/0001558370-24-014867.md) | [451](/filings/0001104659-26-020468.md) | [445](/filings/0001558370-25-007175.md) | [439](/filings/0001558370-25-010804.md) | [433](/filings/0001104659-25-108518.md) | [427](/filings/0001104659-26-092001.md) | [426](/filings/0001104659-26-057964.md) | [498](/filings/0001104659-26-092001.md) |
| Current portion of debt | $m | [38.6](/filings/0001558370-23-018162.md) | [20.3](/filings/0001558370-25-001805.md) | [76.4](/filings/0001558370-24-007517.md) | [22.0](/filings/0001558370-24-011365.md) | [22.3](/filings/0001558370-24-014867.md) | [22.3](/filings/0001104659-26-020468.md) | [22.8](/filings/0001558370-25-007175.md) | [23.1](/filings/0001558370-25-010804.md) | [23.4](/filings/0001104659-25-108518.md) | [23.6](/filings/0001104659-26-092001.md) | [69.8](/filings/0001104659-26-057964.md) | [81.1](/filings/0001104659-26-092001.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [230 d](/filings/0001558370-24-014867.md) | [93.9 d](/filings/0001104659-26-020468.md) | [210](/filings/0001558370-25-007175.md) | [216 d](/filings/0001558370-25-010804.md) | [209 d](/filings/0001104659-25-108518.md) | [168 d](/filings/0001104659-26-020468.md) | [146](/filings/0001104659-26-057964.md) | [152 d](/filings/0001104659-26-092001.md) | [210 d](/filings/0001104659-25-108518.md) | [144 d](/filings/0001104659-26-020468.md) | [106](/filings/0001104659-26-057964.md) | [153 d](/filings/0001104659-26-092001.md) |
| Capital expenditure | $m | [110 d](/filings/0001558370-24-014867.md) | [84.0 d](/filings/0001104659-26-020468.md) | [124](/filings/0001558370-25-007175.md) | [101 d](/filings/0001558370-25-010804.md) | [110 d](/filings/0001104659-25-108518.md) | [93.2 d](/filings/0001104659-26-020468.md) | [86.8](/filings/0001104659-26-057964.md) | [67.0 d](/filings/0001104659-26-092001.md) | [64.7 d](/filings/0001104659-25-108518.md) | [44.8 d](/filings/0001104659-26-020468.md) | [95.7](/filings/0001104659-26-057964.md) | [50.0 d](/filings/0001104659-26-092001.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2010-03-31) | Q2 FY2010 (2010-06-30) | Q3 FY2010 (2010-09-30) | Q1 FY2011 (2011-03-31) | Q2 FY2011 (2011-06-30) | Q3 FY2011 (2011-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [36.7](/filings/0001193125-11-132265.md) | [36.7](/filings/0001193125-11-213708.md) | [36.7](/filings/0001193125-11-301460.md) | [36.7](/filings/0001193125-11-132265.md) | [36.8](/filings/0001193125-11-213708.md) | [36.8](/filings/0001193125-11-301460.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 128,658,801 at 2026-08-06, from the cover of the [10-Q filed 2026-08-06](/filings/0001104659-26-092001.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.